Dosing of Semglee (insulin glargine-yfgn), like Lantus, should be individualized based on the patients needs and should not be used during episodes of hypoglycemia (low blood sugar) or in patients with hypersensitivity to insulin glargine products
How sphingolipids affect T cells in the resolution of inflammation
Opportunity Impact Analysis Omnichannel support hubs: A shared case record is expected to reduce repeated enrollment work
So, GPs will be responsible for ensuring the safety of the process but only to the point that we would for any other private referral, in that we need to provide basic information : however, it is over-stepping to expect a GP to have sufficient specialist knowledge to competently screen the patients medical history, so the sensible and logical response appears to be to reject any request that we screen history for or provide reasons why it should not be prescribed, which requires specialist knowledge outwith GP competence, as normally contained in GMC advice about sticking within your competence
Get support *Based on average weight loss seen in clinical trials .
It causes severe nausea, vomiting, and gastrointestinal distress that can last for days
